Categories: Market News

Earnings preview: What to expect when Hormel reports Q2 2019 results

Hormel Foods Corporation (NYSE: HRL) is scheduled to report second quarter 2019 earnings results on Thursday, May 23, before market open. Analysts expect revenue to increase 2% to $2.3 billion and earnings to improve 2.3% to $0.45 per share on a year-over-year basis.

For the second quarter, Hormel can be expected to benefit
from strength in its refrigerated foods and grocery products segments. However,
weakness in the turkey business is likely to weigh on the topline results for
the period. The company’s bottom line results are likely to be pressured by
higher costs.

During the quarter, Hormel sold its CytoSport business to
PepsiCo Inc. (NASDAQ: PEP) for $465 million. It will be worth watching if the
company has any new plans or strategies following this divestment.

In the first quarter, Hormel reported earnings that matched expectations while revenues fell short. Net sales grew 1.2% to $2.36 billion while EPS fell 21% to $0.44. The company recorded sales increases in all its segments except Jennie-O Turkey Store, which remained flat.

Hormel Q1 2019 Earnings Infographic

For full-year 2019, Hormel expects sales to come in the range of $9.70 billion to $10.20 billion and EPS to be in the range of $1.77 to $1.91. The company expects to incur capital expenditures of around $350 million during the year.

Hormel’s shares have dropped over 5% so far this year. The majority of analysts have rated the stock as Hold.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Share
Published by

Recent Posts

S&P Global (SPGI) reports double-digit growth in Q4 adj. earnings; revenue up 9%

S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…

25 minutes ago

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

38 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

40 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

1 hour ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

1 hour ago

DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs

The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…

1 hour ago